Alliancebernstein L.P. Genmab A/S Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Genmab A/S stock. As of the latest transaction made, Alliancebernstein L.P. holds 14,725,158 shares of GMAB stock, worth $336 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

14,725,158

Previous 14,935,224 1.41%

Holding current value

$336 Million

Previous $312 Million 7.5%

% of portfolio

0.11%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$18.69 - $24.14 $3.93 Million - $5.07 Million	-210,066 Reduced 1.41%	14,725,158 $288 Million
Q4 2024 Feb 12, 2025	SELL	$20.02 - $24.15 $4.02 Million - $4.85 Million	-200,928 Reduced 1.33%	14,935,224 $312 Million
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $2.42 Million - $2.9 Million	-101,687 Reduced 0.67%	15,136,152 $369 Million
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $414,846 - $499,697	-16,508 Reduced 0.11%	15,237,839 $383 Million
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $9.52 Million - $11.8 Million	-360,163 Reduced 2.31%	15,254,347 $456 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $170 Million - $216 Million	6,099,301 Added 64.1%	15,614,510 $497 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $46.8 Million - $56.1 Million	1,327,633 Added 16.22%	9,515,209 $336 Million
Q2 2023 Aug 15, 2023	BUY	$37.4 - $42.94 $53.1 Million - $61 Million	1,420,915 Added 21.0%	8,187,576 $311 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $15 Million - $18.6 Million	431,043 Added 6.8%	6,766,661 $256 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $18.8 Million - $26.2 Million	556,129 Added 9.62%	6,335,618 $269 Million
Q3 2022 Nov 15, 2022	BUY	$31.52 - $373.61 $182 Million - $2.16 Billion	5,779,489 New	5,779,489 $186 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $4.8 Million - $6.31 Million	-133,868 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $316,943 - $371,636	7,628 Added 6.04%	133,868 $5.85 Million
Q2 2021 Jul 30, 2021	BUY	$32.88 - $44.57 $4.15 Million - $5.63 Million	126,240 New	126,240 $5.15 Million
Q4 2020 Feb 08, 2021	SELL	$33.66 - $40.76 $10.4 Million - $12.6 Million	-309,209 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $3.81 Million - $4.46 Million	115,218 Added 59.39%	309,209 $11.3 Million
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $3.89 Million - $6.57 Million	193,991 New	193,991 $6.57 Million

Others Institutions Holding GMAB

# of Institutions

248

Shares Held

66.2M

Call Options Held

729K

Put Options Held

398K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Genmab A/S Transaction History